Impact of red blood cell transfusion strategies in haemato-oncological patients: a systematic review and meta-analysis

British Journal of Haematology

Volumn 178, Issue 1, 2017, Pages 137-151

  Hoeks, Marlijn P A ^a,b   Kranenburg, Floris J ^a,b   Middelburg, Rutger A ^a,b   van Kraaij, Marian G J ^a,c   Zwaginga, Jaap Jan ^a,b  

^a SANQUIN RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

Author keywords

clinical transfusion medicine; liberal; red cell; restrictive

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CHILD; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY RISK; PATIENT SAFETY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME; TREATMENT RESPONSE; ECONOMICS; EVIDENCE BASED MEDICINE; HEMATOLOGIC DISEASE; MORTALITY; PROCEDURES; STATISTICAL BIAS; STATISTICS AND NUMERICAL DATA;

BIAS; ERYTHROCYTE TRANSFUSION; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HEMATOLOGIC NEOPLASMS; HUMANS; PLATELET TRANSFUSION;

EID: 85020188423     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.14641     Document Type: Article

References (43)

1. Allameddine, A., Heaton, M., Jenkins, H., Andrews, S., Sedman, B. & Poarada, C. (2015) The single-unit blood transfusion: experience and impact in haematology patients. Haematologica 100(S1), 19, abstract S139.
2. Arslan, Ö., Toprak, S., Arat, M. & Kayalak, Y. (2004) Hb content-based transfusion policy successfully reduces the number of RBC units transfused. Transfusion, 44, 485–488.
3. Atilla, E., Topcuoglu, P., Yavasoglu, S., Karakaya, A., Gencturk, C., Bozdag, S. & Arslan, O. (2011) A randomized comparison of hemoglobin content-based vs standard (unit-based) RBC transfusion policy efficiencies. Vox Sanguinis, 101(S2), 121, abstract P-303.
4. Bercovitz, R.S., Dietz, A.C., Magid, R.N., Zantek, N.D., Smith, A.R. & Quinones, R.R. (2011) What is the role of red blood cell transfusion threshold on number of transfusions in pediatric patients after hematopoietic stem cell transplant? Blood, 118(21), 1263.
5. Berger, M.D., Gerber, B., Arn, K., Senn, O., Schanz, U. & Stussi, G. (2012) Significant reduction of red blood cell transfusion requirements by changing from a double-unit to a single-unit transfusion policy in patients receiving intensive chemotherapy or stem cell transplantation. Haematologica, 97, 116–122.
6. Bishop, L. (2005) To evaluate the effects of a restrictive and a liberal red blood cell transfusion strategy on fatigue and activity levels of haemato-oncology patients. Bone Marrow Transplantation, 35, S313–S314, abstract P1045.
7. British Committee for Standards in Haematology Blood Transfusion Task Force. (2001) BCSH Guidelines for the clinical use of red cell transfusions. British Journal of Haematology, 113, 24–31.
8. Bruun, M.T., Pendry, K., Georgsen, J., Manzini, P., Lorenzi, M., Wikman, A., Borg-Aquilina, D., van Pampus, E., van Kraaij, M., Fischer, D., Meybohm, P., Zacharowski, K., Geisen, C., Seifried, E., Liumbruno, G., Folléa, G., Grant-Casey, J., Babra, P. & Murphy, M.F. (2016) Patient Blood Management in Europe: surveys on top indications for red blood cell use and patient blood management organization and activities in seven European university hospitals. Vox Sanguinis, 111, 391–398.
9. Butler, C.E., Noel, S., Hibbs, S.P., Miles, D., Staves, J., Mohaghegh, P., Altmann, P., Curnow, E. & Murphy, M.F. (2015) Implementation of a clinical decision support system improves compliance with restrictive transfusion policies in hematology patients. Transfusion, 55, 1964–1971.
10. Carson, J.L., Terrin, M.L., Noveck, H., Sanders, D.W., Chaitman, B.R., Rhoads, G.G., Nemo, G., Dragert, K., Beaupre, L., Hildebrand, K., Macaulay, W., Lewis, C., Cook, D.R., Dobbin, G., Zakriya, K.J., Apple, F.S., Horney, R.A. & Magaziner, J. (2011) Liberal or restrictive transfusion in high-risk patients after hip surgery. New England Journal of Medicine, 365, 2453–2462.
11. Carson, J.L., Grossman, B.J., Kleinman, S., Tinmouth, A.T., Marques, M.B., Fung, M.K., Holcomb, J.B., Illoh, O., Kaplan, L.J., Katz, L.M., Rao, S.V., Roback, J.D., Shander, A., Tobian, A.A., Weinstein, R., Swinton McLaughlin, L.G. & Djulbegovic, B. (2012) Red blood cell transfusion: clinical practice guideline from the AABB. Annals of Internal Medicine, 157, 49–58.
12. Chantepie, S.P., Mear, J.B., Guittet, L., Dervaux, B., Marolleau, J.-P., Jardin, F., Dutheil, J.-J., Parienti, J.-J., Vilque, J.-P. & Reman, O. (2015) Transfusion strategy in hematological intensive care unit study protocol for a randomized controlled trial. Trials, 16, 533.
13. Dersimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled clinical, 7, 177–188.
14. DeZern, A.E., Williams, K., Zahurak, M., Hand, W., Stephens, R.S., King, K.E., Frank, S.M. & Ness, P. (2016) Red blood cell transfusion triggers in acute leukemia: a randomized pilot study. Transfusion, 56, 1750–1757.
15. Haas, F.J. & de Vries, R.R. (2011) CBO guideline blood transfusion. Tijdschrift voor Bloedtransfusie, 4, 102–105.
16. Hajjar, L.A., Vincent, J.-L., Galas, F.R., Nakamura, R.E., Silva, C.M., Santos, M.H., Fukushima, J., Kalil Filho, R., Sierra, D.B., Lopes, N.H., Mauad, T., Roquim, A.C., Sundin, A.C., Leão, W.C., Almeida, J.P., Pomerantzeff, P.M., Dallan, L.O., Jatene, F.B., Stolf, N.A. & Auler, J.O. (2010) Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. Journal of the American Medical Association, 304, 1559–1567.
17. Hebert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I. & Yetisir, E. (1999) A multicenter, randomised controlled clinical trial of transfusion requirements in critical care. Transfusions requirement in critical care. Investigators Canadian Critical Care Trials Group. New England Journal Medicine, 340, 409–417.
18. Hernán, M.A., Hernádez-Díaz, S., Werler, M.M. & Mitchell, A.A. (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. American Journal of Epidemiology, 155, 176–184.
19. Higgins, J.P., Thompson, S.G., Deeks, J.J. & Altman, D.G. (2003) Measuring inconsistency in meta-analysis. British Medical Journal, 327, 557–560.
20. Higgins, J.P., Altman, D.G., Gøtzsche, P.C., Jüni, P., Moher, D., Oxman, A.D., Savović, J., Schulz, K.F., Weeks, L. & Sterne, J.A. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. British Medical Journal, 343, d5928.
21. Ho, C.H. (1998) The hemostatic effect of packed red cell transfusion in patients with anemia. Transfusion, 38, 1011–1014.
22. Hoeg, R.T., Leinoe, E.B., Andersen, P., Klausen, T.W. & Birgens, H.S. (2013) Measuring the impact of a restrictive transfusion guideline in patients with acute myeloid leukaemia. Vox Sanguinis, 105, 81–84.
23. Holst, L.B., Haase, N., Wetterslev, J., Wernerman, J., Guttormsen, A.B., Karlsson, S., Johansson, P.I., Aneman, A., Vang, M.L., Winding, R., Nebrich, L., Nibro, H.L., Rasmussen, B.S., Lauridsen, J.R., Nielsen, J.S., Oldner, A., Pettilä, V., Cronhjort, M.B., Andersen, L.H., Pedersen, U.G., Reiter, N., Wiis, J., White, J.O., Russell, L., Thornberg, K.J., Hjortrup, P.B., Müller, R.G., Møller, M.H., Steensen, M., Tjäder, I., Kilsand, K., Odeberg-Wernerman, S., Sjøbø, B., Bundgaard, H., Thyø, M.A., Lodahl, D., Mærkedahl, R., Albeck, C., Illum, D., Kruse, M., Winkel, P. & Perner, A. (2014) Lower versus higher hemoglobin threshold for transfusion in septic shock. New England Journal Medicine, 371, 1381–1391.
24. Holst, L.B., Petersen, M.W., Haase, N., Perner, A. & Wetterslev, J. (2015) Restrictive versus liberal transfusion strategy for guiding red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. British Medical Journal, 350, h1354.
25. Jansen, A.J., Caljouw, M.A., Hop, W.C., van Rhenen, D.J. & Schipperus, M.R. (2004) Feasibility of a restrictive red-cell transfusion policy for patients with intensive chemotherapy for acute myeloid leukaemia. Transfusion Medicine, 14, 33–38.
26. Jansen, A.J., Bosch, J., Hop, W.C., Beckers, E.A., Schipperus, M.R. & Rhenen, D.J. (2005) Temple study: transfusion effects in myelodysplastic patients, limiting exposure. Vox Sanguinis, 89, 119.
27. Klein, H.G. (1999) Immunomodulatory aspects of transfusion: a once and future risk? Anesthesiology, 91, 861–865.
28. Lacroix, J., Hebert, P.C., Hutchison, J.S. & Huma, H.A. (2007) Transfusion strategies for patients in pediatric intensive care units. New England Journal of Medicine, 356, 1609–1619.
29. Lightdale, J.R., Randolph, A.G., Tran, C.M., Jiang, H., Colon, A., Houlahan, K., Billet, A., Sloan, S. & Lehmann, L.E. (2012) Impact of a conservative red blood cell transfusion strategy in children undergoing hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 18, 813–817.
30. Mear, J.B., Chantepie, S., Gac, A.C., Bazin, A. & Reman, O. (2014) A restrictive strategy reduces the number of transfused packed red blood cells in allograft recipients. Blood, 124(21), 5106. Available at http://www.bloodjournal.org/content/124/21/5106. Last accessed 27 February 2017.
31. Paananen, P., Arola, M.O., Pelliniemi, T., Salmi, T.T. & Lähteenmäki, P.M. (2009) Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 31, 745–749.
32. Patil, N.R., Marques, M., Mineishi, S., Rudolph, S., Vaughan, W., Innis-Shelton, R. & Salzman, D. (2013) A restrictive red cell transfusion approach does not adversely affect day 100 or 1 year survival in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation. Biology of Blood and Marrow Transplantation, 19, S268, abstract 313.
33. Robertson, C.S., Hannay, H.J., Yamal, J.M., Gopinath, S., Goodman, J.C. & Tilley, B.C. (2014) Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. Journal of the American Medical Association, 312, 36–47.
34. Robitaille, N., Lacroix, J., Alexandrov, L., Clayton, L., Cortier, M., Schultz, K.R., Bittencourt, H. & Duval, M. (2013) Excess of veno-occlusive disease in a randomized clinical trial on a higher trigger for red blood cell transfusion after bone marrow transplantation: a Canadian blood and marrow transplant group trial. Biology of Blood and Marrow Transplantation, 19, 468–473.
35. Shander, A., Cappellini, D. & Goodnough, L.T. (2009) Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sanguinis, 97, 185–197.
36. Tay, J., Tinmouth, A., Fergusson, D. & Allan, D. (2011) Transfusion of red cells in hematopoietic stem cell transplantation (TRIST): study protocol for a randomized controlled trial. Trials, 12, 207.
37. Tinegate, H., Pendry, K., Murphy, M., Babra, P., Grant-Casey, J., Hopkinson, C., Hyare, J., Rowley, M., Seeney, F., Watson, D. & Walliss, J. (2016) Where do all the red blood cells (RBCs) go? Result of a survey of RBC use in England and North Wales in 2014. Transfusion, 56, 139–145.
38. Valeri, C.R., Crowley, J.P. & Loscalzo, J. (1998) The red cell transfusion trigger: has a sin of commission now become a sin of omission? Transfusion, 38, 602–610.
39. Valeri, C.R., Cassidy, G., Pivacek, L.E., Ragno, G., Lieberthal, W., Crowley, J.P., Khuri, S.F. & Loscalzo, J. (2001) Anemia-induced increase in the bleeding time: implications for treatment of nonsurgical blood loss. Transfusion, 41, 977–983.
40. Villanueva, C., Colomo, A., Bosch, A., Concepción, M., Hernandez-Gea, V., Aracil, C., Graupera, I., Poca, M., Alvarez-Urturi, C., Gordillo, J., Guarner-Argente, C., Santaló, M., Muñiz, E. & Guarner, C. (2013) Transfusion strategies for upper gastrointestinal bleeding. New England Journal of Medicine, 368, 11–21.
41. Wan, X., Wang, W., Liu, J. & Tong, T. (2014) Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Medical Research Methodology, 14, 135.
42. Webert, K.E., Cook, R.J., Couban, S., Carruthers, J., Lee, K., Blajchman, M.A., Lipton, J.H., Brandwein, J.M. & Heddle, N.M. (2008) A multicenter pilot-randomized controlled trial of an augmented red blood cell transfusion strategy for patients treated with induction chemotherapy for acute leukemia or stem cell transplantation. Transfusion, 48, 81–91.
43. Wells, G.A., Shea, B., O'Connell, D., Peterson, J., Welch, V., Losos, M. & Tugwell, P. (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2000. Available at http://www.medicine.mcgill.ca/rtamblyn/Readings%5CThe%20Newcastle%20-%20Scale%20for%20assessing%20the%20quality%20of%20nonrandomised%20studies%20in%20meta-analyses.pdf. Last accessed 2 September 2016.